ConductScience.org, home

Paper3765601

Antihypertensive therapy, serum lipids, coronary heart disease and hypertension--balancing the risks and benefits of treatment.

Houston MC. West J Med, 1986. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Antihypertensive therapy, serum lipids, coronary heart disease and hypertension--balancing the risks and benefits of treatment. Papers, record 3765601. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3765601

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antihypertensive therapy, serum lipids, coronary heart disease and hypertension--balancing the risks and benefits of treatment.
PubMed
Journal
West J Med
PubMed
Year
1986
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.09
iCite
Revised in PubMed
2018-11-13
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Houston MCM C

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Coronary DiseaseMajor topic
HypertensionMajor topic
LipidsMajor topic
Adult
Antihypertensive Agents
Female
Humans
Male
Middle Aged
Risk

Source PubMed

Download CSV of topics

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14403533A primary preventive study of Gothenburg, Sweden.Prev Med1972https://conductscience.org/library/papers/4403533PubMed
214485566The effect of oral hydralazine on circulating human cholesterol.Am J Med Sci1962https://conductscience.org/library/papers/14485566PubMed
3796642Optimal dose of a thiazide diuretic.Med J Aust1976https://conductscience.org/library/papers/796642PubMed
4140029Treatment of mild hypertension: results of a ten-year intervention trial.Circ Res1977https://conductscience.org/library/papers/140029PubMed
5361988Prazosin and clonidine for moderately severe hypertension.JAMA1978https://conductscience.org/library/papers/361988PubMed
67001898Treatment of mild hypertension: a five year controlled drug trial. The Oslo study.Am J Med1980https://conductscience.org/library/papers/7001898PubMed
77447225Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients: a double-blind controlled trial.Ann Intern Med1981https://conductscience.org/library/papers/7447225PubMed
87037030Oxprenolol, methyldopa and lipids in diabetes mellitus.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7037030PubMed
96177958Antihypertensive therapy and the risk of coronary heart disease.J Cardiovasc Pharmacol1982https://conductscience.org/library/papers/6177958PubMed
106177962Effect of prazosin on serum lipids.J Cardiovasc Pharmacol1982https://conductscience.org/library/papers/6177962PubMed
116869207Some wrong-way chemical changes during antihypertensive treatment: comparison of indapamide and related agents.Am Heart J1983https://conductscience.org/library/papers/6869207PubMed
126367446Effects of long-term prazosin therapy on lipoprotein metabolism in hypertensive patients.Am J Med1984https://conductscience.org/library/papers/6367446PubMed
136702863Effects of diuretic and beta-blocker therapy in the Medical Research Council Trial.Am J Med1984https://conductscience.org/library/papers/6702863PubMed
146712367Serum cholesterol during treatment of hypertension with diuretic drugs.Arch Intern Med1984https://conductscience.org/library/papers/6712367PubMed
156327117Optimal resources for primary prevention of atherosclerotic diseases. Atherosclerosis Study Group.Circulation1984https://conductscience.org/library/papers/6327117PubMed
166744774Serum lipids in normo- and hyperlipidemics after methyldopa and propranolol.Clin Pharmacol Ther1984https://conductscience.org/library/papers/6744774PubMed
176084135Antihypertensive treatment: cardiovascular risks and monotherapy.J Cardiovasc Pharmacol1984https://conductscience.org/library/papers/6084135PubMed
186084137Effects of guanabenz on plasma lipid levels in hypertensive patients.J Cardiovasc Pharmacol1984https://conductscience.org/library/papers/6084137PubMed
192859784Effect of beta blockers on blood lipid profile.Am Heart J1985https://conductscience.org/library/papers/2859784PubMed
202860883Antihypertensive therapy and lipids. Evidence, mechanisms, and implications.Arch Intern Med1985https://conductscience.org/library/papers/2860883PubMed

See all 27 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn Papers
32042057Nuclear Translocation of Glutaminase GLS2 in Human Cancer Cells Associates with Proliferation Arrest and Differentiation.Sci Rep2020https://conductscience.org/library/papers/32042057

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3765601

GET https://conductscience.org/api/papers/v1/3765601/references?page=2